| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 0.1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |